President Donald Trump intensified his assertions — without evidence — that officials using an autopen undermined the actions ...

Luton, Bedfordshire, United Kingdom, June 05, 2025 (GLOBE NEWSWIRE) -- The global pediatric glioma drugs market is poised for substantial growth, with an estimated value of approximately USD 5 billion ...

Annual Meeting held in Chicago, USA, from May 30 to June 3, the results of the Phase Ib/II clinical study of 9MW2821 in combination with Toripalimab for the treatment of patients with locally advanced ...

A woman was caught with an MK2 grenade fleeing a police checkpoint in Loei. Claiming self-defence, the suspect is linked to drug activities.

Adding the immune checkpoint inhibitor durvalumab (Imfinzi ... Safety outcomes were similar in both the durvalumab and placebo groups, Janjigian said. “Grade 3 and 4 treatment-related adverse events ...

Grade 1 cytokine release syndrome (CRS) was observed in 2 patients—1 each from the DL3 and DL4 cohorts—and fever was the only symptom. The CRS events occurred 6 days following infusion in the patient ...

Tarlatamab prolonged both overall and progression-free survival in the treatment of small cell lung cancer, backing it as a ...

Several oral abstracts presented at the American Society of Clinical Oncology’s annual meeting highlight ongoing research of Keytruda, Opdivo, Tecentriq and more in skin cancer.